EMEA (Europe, Middle East and Africa) Acute Lung Injury Market Report 2017

December 2017 | 112 pages | ID: EAB3D916924EN
QYResearch

Abstracts

In this report, the EMEA Acute Lung Injury market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (Units), revenue (Million USD), market share and growth rate of Acute Lung Injury for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Acute Lung Injury market competition by top manufacturers/players, with Acute Lung Injury sales volume (Units), price (K USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including

• GSK
• Altor BioScience Corp
• Faron Pharmaceuticals Oy
• Altor BioScience Corp
• APEPTICO
• KYORIN Pharmaceutical
• Bachem Holding
• Discovery Laboratories
• Carolus Therapeutics
• Prometic Life Sciences
• Aqualung Therapeutics

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• Clinic
• Hospital

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Acute Lung Injury
• Other

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Acute Lung Injury Market Report 2017

1 ACUTE LUNG INJURY OVERVIEW

1.1 Product Overview and Scope of Acute Lung Injury
1.2 Classification of Acute Lung Injury
  1.2.1 EMEA Acute Lung Injury Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Acute Lung Injury Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Clinic
  1.2.4 Hospital
1.3 EMEA Acute Lung Injury Market by Application/End Users
  1.3.1 EMEA Acute Lung Injury Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Acute Lung Injury
  1.3.3 Other
1.4 EMEA Acute Lung Injury Market by Region
  1.4.1 EMEA Acute Lung Injury Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Acute Lung Injury (2012-2022)
  1.5.1 EMEA Acute Lung Injury Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Acute Lung Injury Revenue and Growth Rate (2012-2022)

2 EMEA ACUTE LUNG INJURY COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Acute Lung Injury Market Competition by Players/Manufacturers
  2.1.1 EMEA Acute Lung Injury Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Acute Lung Injury Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Acute Lung Injury Sale Price by Players (2012-2017)
2.2 EMEA Acute Lung Injury (Volume and Value) by Type/Product Category
  2.2.1 EMEA Acute Lung Injury Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Acute Lung Injury Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Acute Lung Injury Sale Price by Type (2012-2017)
2.3 EMEA Acute Lung Injury (Volume) by Application
2.4 EMEA Acute Lung Injury (Volume and Value) by Region
  2.4.1 EMEA Acute Lung Injury Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Acute Lung Injury Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Acute Lung Injury Sales Price by Region (2012-2017)

3 EUROPE ACUTE LUNG INJURY (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Acute Lung Injury Sales and Value (2012-2017)
  3.1.1 Europe Acute Lung Injury Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Acute Lung Injury Revenue and Growth Rate (2012-2017)
3.2 Europe Acute Lung Injury Sales and Market Share by Type
3.3 Europe Acute Lung Injury Sales and Market Share by Application
3.4 Europe Acute Lung Injury Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Acute Lung Injury Sales Volume by Countries (2012-2017)
  3.4.2 Europe Acute Lung Injury Revenue by Countries (2012-2017)
  3.4.3 Germany Acute Lung Injury Sales and Growth Rate (2012-2017)
  3.4.4 France Acute Lung Injury Sales and Growth Rate (2012-2017)
  3.4.5 UK Acute Lung Injury Sales and Growth Rate (2012-2017)
  3.4.6 Russia Acute Lung Injury Sales and Growth Rate (2012-2017)
  3.4.7 Italy Acute Lung Injury Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Acute Lung Injury Sales and Growth Rate (2012-2017)

4 MIDDLE EAST ACUTE LUNG INJURY (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Acute Lung Injury Sales and Value (2012-2017)
  4.1.1 Middle East Acute Lung Injury Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Acute Lung Injury Revenue and Growth Rate (2012-2017)
4.2 Middle East Acute Lung Injury Sales and Market Share by Type
4.3 Middle East Acute Lung Injury Sales and Market Share by Application
4.4 Middle East Acute Lung Injury Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Acute Lung Injury Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Acute Lung Injury Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Acute Lung Injury Sales and Growth Rate (2012-2017)
  4.4.4 Israel Acute Lung Injury Sales and Growth Rate (2012-2017)
  4.4.5 UAE Acute Lung Injury Sales and Growth Rate (2012-2017)
  4.4.6 Iran Acute Lung Injury Sales and Growth Rate (2012-2017)

5 AFRICA ACUTE LUNG INJURY (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Acute Lung Injury Sales and Value (2012-2017)
  5.1.1 Africa Acute Lung Injury Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Acute Lung Injury Revenue and Growth Rate (2012-2017)
5.2 Africa Acute Lung Injury Sales and Market Share by Type
5.3 Africa Acute Lung Injury Sales and Market Share by Application
5.4 Africa Acute Lung Injury Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Acute Lung Injury Sales Volume by Countries (2012-2017)
  5.4.2 Africa Acute Lung Injury Revenue by Countries (2012-2017)
  5.4.3 South Africa Acute Lung Injury Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Acute Lung Injury Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Acute Lung Injury Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Acute Lung Injury Sales and Growth Rate (2012-2017)

6 EMEA ACUTE LUNG INJURY MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 GSK
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Acute Lung Injury Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 GSK Acute Lung Injury Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Altor BioScience Corp
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Acute Lung Injury Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Altor BioScience Corp Acute Lung Injury Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Faron Pharmaceuticals Oy
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Acute Lung Injury Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Faron Pharmaceuticals Oy Acute Lung Injury Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Altor BioScience Corp
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Acute Lung Injury Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Altor BioScience Corp Acute Lung Injury Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 APEPTICO
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Acute Lung Injury Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 APEPTICO Acute Lung Injury Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 KYORIN Pharmaceutical
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Acute Lung Injury Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 KYORIN Pharmaceutical Acute Lung Injury Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Bachem Holding
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Acute Lung Injury Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Bachem Holding Acute Lung Injury Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Discovery Laboratories
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Acute Lung Injury Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Discovery Laboratories Acute Lung Injury Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Carolus Therapeutics
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Acute Lung Injury Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Carolus Therapeutics Acute Lung Injury Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Prometic Life Sciences
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Acute Lung Injury Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Prometic Life Sciences Acute Lung Injury Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Aqualung Therapeutics

7 ACUTE LUNG INJURY MANUFACTURING COST ANALYSIS

7.1 Acute Lung Injury Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Acute Lung Injury

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Acute Lung Injury Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Acute Lung Injury Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA ACUTE LUNG INJURY MARKET FORECAST (2017-2022)

11.1 EMEA Acute Lung Injury Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Acute Lung Injury Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Acute Lung Injury Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Acute Lung Injury Price and Trend Forecast (2017-2022)
11.2 EMEA Acute Lung Injury Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Acute Lung Injury Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Acute Lung Injury Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Acute Lung Injury Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Acute Lung Injury Sales Forecast by Type (2017-2022)
11.7 EMEA Acute Lung Injury Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Acute Lung Injury
Figure EMEA Acute Lung Injury Sales Volume (Units) by Type (2012-2022)
Figure EMEA Acute Lung Injury Sales Volume Market Share by Type (Product Category) in 2016
Figure Clinic Product Picture
Figure Hospital Product Picture
Figure EMEA Acute Lung Injury Sales Volume (Units) by Application (2012-2022)
Figure EMEA Sales Market Share of Acute Lung Injury by Application in 2016
Figure Acute Lung Injury Examples
Table Key Downstream Customer in Acute Lung Injury
Figure Other Examples
Table Key Downstream Customer in Other
Figure EMEA Acute Lung Injury Market Size (Million USD) by Region (2012-2022)
Figure Europe Acute Lung Injury Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Acute Lung Injury Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Acute Lung Injury Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Acute Lung Injury Revenue (Million USD) Status and Forecast by Countries
Figure Africa Acute Lung Injury Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Acute Lung Injury Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Acute Lung Injury Sales Volume and Growth Rate (2012-2022)
Figure EMEA Acute Lung Injury Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Acute Lung Injury Market Major Players Product Sales Volume (Units) (2012-2017)
Table EMEA Acute Lung Injury Sales Volume (Units) of Major Players (2012-2017)
Table EMEA Acute Lung Injury Sales Share by Players (2012-2017)
Figure 2016 Acute Lung Injury Sales Share by Players
Figure 2017 Acute Lung Injury Sales Share by Players
Figure EMEA Acute Lung Injury Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Acute Lung Injury Revenue (Million USD) by Players (2012-2017)
Table EMEA Acute Lung Injury Revenue Share by Players (2012-2017)
Table 2016 EMEA Acute Lung Injury Revenue Share by Players
Table 2017 EMEA Acute Lung Injury Revenue Share by Players
Table EMEA Acute Lung Injury Sale Price (K USD/Unit) by Players (2012-2017)
Table EMEA Acute Lung Injury Sales (Units) and Market Share by Type (2012-2017)
Table EMEA Acute Lung Injury Sales Share by Type (2012-2017)
Figure Sales Market Share of Acute Lung Injury by Type (2012-2017)
Figure EMEA Acute Lung Injury Sales Market Share by Type (2012-2017)
Table EMEA Acute Lung Injury Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Acute Lung Injury Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Acute Lung Injury by Type in 2016
Table EMEA Acute Lung Injury Sale Price (K USD/Unit) by Type (2012-2017)
Table EMEA Acute Lung Injury Sales (Units) and Market Share by Application (2012-2017)
Table EMEA Acute Lung Injury Sales Share by Application (2012-2017)
Figure Sales Market Share of Acute Lung Injury by Application (2012-2017)
Figure EMEA Acute Lung Injury Sales Market Share by Application in 2016
Table EMEA Acute Lung Injury Sales (Units) and Market Share by Region (2012-2017)
Table EMEA Acute Lung Injury Sales Share by Region (2012-2017)
Figure Sales Market Share of Acute Lung Injury by Region (2012-2017)
Figure EMEA Acute Lung Injury Sales Market Share in 2016
Table EMEA Acute Lung Injury Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Acute Lung Injury Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Acute Lung Injury by Region (2012-2017)
Figure EMEA Acute Lung Injury Revenue Market Share Regions in 2016
Table EMEA Acute Lung Injury Sales Price (K USD/Unit) by Region (2012-2017)
Figure Europe Acute Lung Injury Sales (Units) and Growth Rate (2012-2017)
Figure Europe Acute Lung Injury Revenue and Growth Rate (2012-2017)
Table Europe Acute Lung Injury Sales (Units) by Type (2012-2017)
Table Europe Acute Lung Injury Market Share by Type (2012-2017)
Figure Europe Acute Lung Injury Market Share by Type in 2016
Table Europe Acute Lung Injury Sales (Units) by Application (2012-2017)
Table Europe Acute Lung Injury Market Share by Application (2012-2017)
Figure Europe Acute Lung Injury Market Share by Application in 2016
Table Europe Acute Lung Injury Sales (Units) by Countries (2012-2017)
Table Europe Acute Lung Injury Sales Market Share by Countries (2012-2017)
Figure Europe Acute Lung Injury Sales Market Share by Countries (2012-2017)
Figure Europe Acute Lung Injury Sales Market Share by Countries in 2016
Table Europe Acute Lung Injury Revenue (Million USD) by Countries (2012-2017)
Table Europe Acute Lung Injury Revenue Market Share by Countries (2012-2017)
Figure Europe Acute Lung Injury Revenue Market Share by Countries (2012-2017)
Figure Europe Acute Lung Injury Revenue Market Share by Countries in 2016
Figure Germany Acute Lung Injury Sales (Units) and Growth Rate (2012-2017)
Figure France Acute Lung Injury Sales (Units) and Growth Rate (2012-2017)
Figure UK Acute Lung Injury Sales (Units) and Growth Rate (2012-2017)
Figure Russia Acute Lung Injury Sales (Units) and Growth Rate (2012-2017)
Figure Italy Acute Lung Injury Sales (Units) and Growth Rate (2012-2017)
Figure Benelux Acute Lung Injury Sales (Units) and Growth Rate (2012-2017)
Figure Middle East Acute Lung Injury Sales (Units) and Growth Rate (2012-2017)
Figure Middle East Acute Lung Injury Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Acute Lung Injury Sales (Units) by Type (2012-2017)
Table Middle East Acute Lung Injury Market Share by Type (2012-2017)
Figure Middle East Acute Lung Injury Market Share by Type (2012-2017)
Table Middle East Acute Lung Injury Sales (Units) by Applications (2012-2017)
Table Middle East Acute Lung Injury Market Share by Applications (2012-2017)
Figure Middle East Acute Lung Injury Sales Market Share by Application in 2016
Table Middle East Acute Lung Injury Sales Volume (Units) by Countries (2012-2017)
Table Middle East Acute Lung Injury Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Acute Lung Injury Sales Volume Market Share by Countries in 2016
Table Middle East Acute Lung Injury Revenue (Million USD) by Countries (2012-2017)
Table Middle East Acute Lung Injury Revenue Market Share by Countries (2012-2017)
Figure Middle East Acute Lung Injury Revenue Market Share by Countries (2012-2017)
Figure Middle East Acute Lung Injury Revenue Market Share by Countries in 2016
Figure Saudi Arabia Acute Lung Injury Sales (Units) and Growth Rate (2012-2017)
Figure Israel Acute Lung Injury Sales (Units) and Growth Rate (2012-2017)
Figure UAE Acute Lung Injury Sales (Units) and Growth Rate (2012-2017)
Figure Iran Acute Lung Injury Sales (Units) and Growth Rate (2012-2017)
Figure Africa Acute Lung Injury Sales (Units) and Growth Rate (2012-2017)
Figure Africa Acute Lung Injury Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Acute Lung Injury Sales (Units) by Type (2012-2017)
Table Africa Acute Lung Injury Sales Market Share by Type (2012-2017)
Figure Africa Acute Lung Injury Sales Market Share by Type (2012-2017)
Figure Africa Acute Lung Injury Sales Market Share by Type in 2016
Table Africa Acute Lung Injury Sales (Units) by Application (2012-2017)
Table Africa Acute Lung Injury Sales Market Share by Application (2012-2017)
Figure Africa Acute Lung Injury Sales Market Share by Application (2012-2017)
Table Africa Acute Lung Injury Sales Volume (Units) by Countries (2012-2017)
Table Africa Acute Lung Injury Sales Market Share by Countries (2012-2017)
Figure Africa Acute Lung Injury Sales Market Share by Countries (2012-2017)
Figure Africa Acute Lung Injury Sales Market Share by Countries in 2016
Table Africa Acute Lung Injury Revenue (Million USD) by Countries (2012-2017)
Table Africa Acute Lung Injury Revenue Market Share by Countries (2012-2017)
Figure Africa Acute Lung Injury Revenue Market Share by Countries (2012-2017)
Figure Africa Acute Lung Injury Revenue Market Share by Countries in 2016
Figure South Africa Acute Lung Injury Sales (Units) and Growth Rate (2012-2017)
Figure Nigeria Acute Lung Injury Sales (Units) and Growth Rate (2012-2017)
Figure Egypt Acute Lung Injury Sales (Units) and Growth Rate (2012-2017)
Figure Algeria Acute Lung Injury Sales (Units) and Growth Rate (2012-2017)
Table GSK Acute Lung Injury Basic Information List
Table GSK Acute Lung Injury Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure GSK Acute Lung Injury Sales (Units) and Growth Rate (2012-2017)
Figure GSK Acute Lung Injury Sales Market Share in EMEA (2012-2017)
Figure GSK Acute Lung Injury Revenue Market Share in EMEA (2012-2017)
Table Altor BioScience Corp Acute Lung Injury Basic Information List
Table Altor BioScience Corp Acute Lung Injury Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Altor BioScience Corp Acute Lung Injury Sales (Units) and Growth Rate (2012-2017)
Figure Altor BioScience Corp Acute Lung Injury Sales Market Share in EMEA (2012-2017)
Figure Altor BioScience Corp Acute Lung Injury Revenue Market Share in EMEA (2012-2017)
Table Faron Pharmaceuticals Oy Acute Lung Injury Basic Information List
Table Faron Pharmaceuticals Oy Acute Lung Injury Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Faron Pharmaceuticals Oy Acute Lung Injury Sales (Units) and Growth Rate (2012-2017)
Figure Faron Pharmaceuticals Oy Acute Lung Injury Sales Market Share in EMEA (2012-2017)
Figure Faron Pharmaceuticals Oy Acute Lung Injury Revenue Market Share in EMEA (2012-2017)
Table Altor BioScience Corp Acute Lung Injury Basic Information List
Table Altor BioScience Corp Acute Lung Injury Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Altor BioScience Corp Acute Lung Injury Sales (Units) and Growth Rate (2012-2017)
Figure Altor BioScience Corp Acute Lung Injury Sales Market Share in EMEA (2012-2017)
Figure Altor BioScience Corp Acute Lung Injury Revenue Market Share in EMEA (2012-2017)
Table APEPTICO Acute Lung Injury Basic Information List
Table APEPTICO Acute Lung Injury Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure APEPTICO Acute Lung Injury Sales (Units) and Growth Rate (2012-2017)
Figure APEPTICO Acute Lung Injury Sales Market Share in EMEA (2012-2017)
Figure APEPTICO Acute Lung Injury Revenue Market Share in EMEA (2012-2017)
Table KYORIN Pharmaceutical Acute Lung Injury Basic Information List
Table KYORIN Pharmaceutical Acute Lung Injury Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure KYORIN Pharmaceutical Acute Lung Injury Sales (Units) and Growth Rate (2012-2017)
Figure KYORIN Pharmaceutical Acute Lung Injury Sales Market Share in EMEA (2012-2017)
Figure KYORIN Pharmaceutical Acute Lung Injury Revenue Market Share in EMEA (2012-2017)
Table Bachem Holding Acute Lung Injury Basic Information List
Table Bachem Holding Acute Lung Injury Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Bachem Holding Acute Lung Injury Sales (Units) and Growth Rate (2012-2017)
Figure Bachem Holding Acute Lung Injury Sales Market Share in EMEA (2012-2017)
Figure Bachem Holding Acute Lung Injury Revenue Market Share in EMEA (2012-2017)
Table Discovery Laboratories Acute Lung Injury Basic Information List
Table Discovery Laboratories Acute Lung Injury Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Discovery Laboratories Acute Lung Injury Sales (Units) and Growth Rate (2012-2017)
Figure Discovery Laboratories Acute Lung Injury Sales Market Share in EMEA (2012-2017)
Figure Discovery Laboratories Acute Lung Injury Revenue Market Share in EMEA (2012-2017)
Table Carolus Therapeutics Acute Lung Injury Basic Information List
Table Carolus Therapeutics Acute Lung Injury Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Carolus Therapeutics Acute Lung Injury Sales (Units) and Growth Rate (2012-2017)
Figure Carolus Therapeutics Acute Lung Injury Sales Market Share in EMEA (2012-2017)
Figure Carolus Therapeutics Acute Lung Injury Revenue Market Share in EMEA (2012-2017)
Table Prometic Life Sciences Acute Lung Injury Basic Information List
Table Prometic Life Sciences Acute Lung Injury Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Prometic Life Sciences Acute Lung Injury Sales (Units) and Growth Rate (2012-2017)
Figure Prometic Life Sciences Acute Lung Injury Sales Market Share in EMEA (2012-2017)
Figure Prometic Life Sciences Acute Lung Injury Revenue Market Share in EMEA (2012-2017)
Table Aqualung Therapeutics Acute Lung Injury Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Acute Lung Injury
Figure Manufacturing Process Analysis of Acute Lung Injury
Figure Acute Lung Injury Industrial Chain Analysis
Table Raw Materials Sources of Acute Lung Injury Major Manufacturers in 2016
Table Major Buyers of Acute Lung Injury
Table Distributors/Traders List
Figure EMEA Acute Lung Injury Sales (Units) and Growth Rate Forecast (2017-2022)
Figure EMEA Acute Lung Injury Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Acute Lung Injury Price (K USD/Unit) and Trend Forecast (2017-2022)
Table EMEA Acute Lung Injury Sales (Units) Forecast by Region (2017-2022)
Figure EMEA Acute Lung Injury Sales Market Share Forecast by Region (2017-2022)
Table EMEA Acute Lung Injury Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Acute Lung Injury Revenue Market Share Forecast by Region (2017-2022)
Table Europe Acute Lung Injury Sales (Units) Forecast by Countries (2017-2022)
Figure Europe Acute Lung Injury Sales Market Share Forecast by Countries (2017-2022)
Table Europe Acute Lung Injury Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Acute Lung Injury Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Acute Lung Injury Sales (Units) Forecast by Countries (2017-2022)
Figure Middle East Acute Lung Injury Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Acute Lung Injury Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Acute Lung Injury Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Acute Lung Injury Sales (Units) Forecast by Countries (2017-2022)
Figure Africa Acute Lung Injury Sales Market Share Forecast by Countries (2017-2022)
Table Africa Acute Lung Injury Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Acute Lung Injury Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Acute Lung Injury Sales (Units) Forecast by Type (2017-2022)
Figure EMEA Acute Lung Injury Sales Market Share Forecast by Type (2017-2022)
Table EMEA Acute Lung Injury Sales (Units) Forecast by Application (2017-2022)
Figure EMEA Acute Lung Injury Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources